Home › Epilepsy › Illinois
Epilepsy clinical trials in Illinois
8 studies for Epilepsy are looking for participants at sites in Illinois.
Cities in Illinois
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Re:Cognition Health-Chicago, Chicago
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07594119A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- Northwestern University, Chicago
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Aug 24, 2026 · NCT06132893A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Southern Illinois University School of Medicine, Springfield
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 10, 2026 · NCT05667142Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingObservational study
Up to age 26 · All sexes · Updated Aug 6, 2026 · NCT05374824A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Praxis Research Site, Chicago
RecruitingPhase 3
1 Day – 18 Years · All sexes · Updated Aug 3, 2026 · NCT07019922Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Rush University Medical Center, Chicago
- University of Chicago, Chicago
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Southern Illinois University School of Medicine, Springfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05716100Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
- Lurie Children's Hospital of Chicago, Chicago
RecruitingPhase 2
1 Day – 6 Months · All sexes · Updated Jan 22, 2026 · NCT05104983From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.